Literature DB >> 21530399

Immunohistochemical analysis of FKBP51 in human cancers.

Stefania Staibano1, Massimo Mascolo, Gennaro Ilardi, Maria Siano, Gaetano De Rosa.   

Abstract

FKBP51 is a FK506-binding immunophilin involved in the regulation of several fundamental biological processes. A growing body of data indicates that this protein has also a role in the abnormal cell growth of cancers, and could be considered as a promising new marker of tumor progression and response to radio/chemotherapy. However, the data concerning the expression of FKBP51 in cancer are not conclusive, and partially contradictory. They delineate a very complex scenario, in which many molecular FKBP51-related pathways are variously intersected among different tumors. This review reports the available data concerning FKBP51 expression in normal tissues and human malignancies, outlining the role of the immunohistochemical analysis as a fundamental tool for better understanding the role of this immunophilin in cancer biology.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530399     DOI: 10.1016/j.coph.2011.04.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  7 in total

1.  USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.

Authors:  Kuntian Luo; Yunhui Li; Yujiao Yin; Lei Li; Chenming Wu; Yuping Chen; Somaira Nowsheen; Qi Hu; Lizhi Zhang; Zhenkun Lou; Jian Yuan
Journal:  EMBO J       Date:  2017-03-31       Impact factor: 11.598

2.  Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.

Authors:  Eric Smith; Helen M Palethorpe; Andrew R Ruszkiewicz; Suzanne Edwards; Damien A Leach; Tim J Underwood; Eleanor F Need; Paul A Drew
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

3.  FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?

Authors:  Daniela Russo; Francesco Merolla; Massimo Mascolo; Gennaro Ilardi; Simona Romano; Silvia Varricchio; Virginia Napolitano; Angela Celetti; Loredana Postiglione; Pier Paolo Di Lorenzo; Luigi Califano; Giovanni Orabona Dell'Aversana; Fabio Astarita; Maria Fiammetta Romano; Stefania Staibano
Journal:  Int J Mol Sci       Date:  2017-02-18       Impact factor: 5.923

4.  FKBP51 induces p53-dependent apoptosis and enhances drug sensitivity of human non-small-cell lung cancer cells.

Authors:  Yu Chen; Zhiqiang Liu; Yuequn Wang; Jian Zhuang; Yun Peng; Xiaoyang Mo; Jimei Chen; Yan Shi; Mengxiong Yu; Wanwan Cai; Yahuan Li; Xiaolan Zhu; Wuzhou Yuan; Yongqing Li; Fang Li; Zuoqiong Zhou; Guo Dai; Xiangli Ye; Yongqi Wan; Zhigang Jiang; Ping Zhu; Xiongwei Fan; Xiushan Wu
Journal:  Exp Ther Med       Date:  2020-01-14       Impact factor: 2.447

5.  Dexamethasone Sensitizes Acute Monocytic Leukemia Cells to Ara-C by Upregulating FKBP51.

Authors:  Huanxin Sun; Xiaowen Liu; Laicheng Wang; Bin Cui; Wenli Mu; Yu Xia; Shuang Liu; Xin Liu; Yulian Jiao; Yueran Zhao
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

6.  New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment.

Authors:  Giovanni Cugliari; Alessandra Allione; Alessia Russo; Chiara Catalano; Elisabetta Casalone; Simonetta Guarrera; Federica Grosso; Daniela Ferrante; Marika Sculco; Marta La Vecchia; Chiara Pirazzini; Roberta Libener; Dario Mirabelli; Corrado Magnani; Irma Dianzani; Giuseppe Matullo
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

7.  FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.

Authors:  Jing Dong; Yulian Jiao; Wenli Mu; Bingru Lu; Muyun Wei; Linying Sun; Shengnan Hu; Bin Cui; Xiaowen Liu; Zijiang Chen; Yueran Zhao
Journal:  Oncotarget       Date:  2017-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.